Homology Medicines Inc - ESG Rating & Company Profile powered by AI
This ESG score for Homology Medicines Inc indicates the company's transparency towards the United Nations Sustainable Development Goals. The webpage includes a questions and answers section on Homology Medicines Inc. Browse to the end of this webpage for potential risks for Homology Medicines Inc based on industry, geography and marketcap.
Homology Medicines Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 6.0, social score of 3.2 and governance score of 6.4.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 658 | Transchem Ltd | 5.3 | High |
| 658 | Zenith Healthcare Ltd | 5.3 | High |
| 687 | Homology Medicines Inc | 5.2 | High |
| 687 | Cardiol Therapeutics Inc | 5.2 | High |
| 687 | Cell Source Inc | 5.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Homology Medicines Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Homology Medicines Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Homology Medicines Inc report the average age of the workforce?
Sign up for free to unlockDoes Homology Medicines Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Homology Medicines Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Homology Medicines Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Homology Medicines Inc offer flexible work?
Sign up for free to unlockDoes Homology Medicines Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Homology Medicines Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Homology Medicines Inc conduct supply chain audits?
Sign up for free to unlockDoes Homology Medicines Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Homology Medicines Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Homology Medicines Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Homology Medicines Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Homology Medicines Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Homology Medicines Inc disclose water use targets?
Sign up for free to unlockDoes Homology Medicines Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Homology Medicines Inc have a product recall in the last two years?
Sign up for free to unlockDoes Homology Medicines Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Homology Medicines Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Homology Medicines Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Homology Medicines Inc disclose parental leave metrics?
Sign up for free to unlockDoes Homology Medicines Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Homology Medicines Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Homology Medicines Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Homology Medicines Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Homology Medicines Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Homology Medicines Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Homology Medicines Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Homology Medicines Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Homology Medicines Inc disclose its waste policy?
Sign up for free to unlockDoes Homology Medicines Inc report according to TCFD requirements?
Sign up for free to unlockDoes Homology Medicines Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Homology Medicines Inc disclose energy use targets?
Sign up for free to unlockDoes Homology Medicines Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Homology Medicines Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Homology Medicines Inc
These potential risks are based on the size, segment and geographies of the company.
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.